Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways (Q40302272)

19 September 2017

title

Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways (English)

1 reference

19 September 2017

1 reference

1 reference

Wang TH

1 reference

19 September 2017

Chan YH

1 reference

19 September 2017

Chen CW

1 reference

19 September 2017

Kung WH

1 reference

19 September 2017

Lee YS

1 reference

19 September 2017

Wang ST

1 reference

19 September 2017

Chang TC

1 reference

19 September 2017

Wang HS

1 reference

19 September 2017

language of work or name

English

0 references

publication date

20 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

4857-4866

1 reference

Statistical tests for differential expression in cDNA microarray experiments

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

The specificities of protein kinase inhibitors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Molecular effects of paclitaxel: myths and reality (a critical review).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Fundamentals of experimental design for cDNA microarrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Shared actions of endotoxin and taxol on TNF receptors and TNF release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Microtubules as a target for anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

p53-independent apoptosis induced by paclitaxel through an indirect mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Identification of Tumor-Specific Paclitaxel (Taxol)-Responsive Regulatory Elements in the Interleukin-8 Promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Bioinformatic mapping of AlkB homology domains in viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

A genetically defined model for human ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

MEK inhibition enhances paclitaxel-induced tumor apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

1 reference

7 January 2021

Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209498

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209498

1 reference

Dimensions Publication ID

19 September 2017

1018998904

0 references

1 reference